Trials / Completed
CompletedNCT00805584
Study of Nasal Symptom Relief and Side Effects in Hayfever Patients Treated With Aerius (Desloratadine)(P03442)
A Multi-center, Open-label, Non-comparative Study of the Relief of Nasal Symptoms and Tolerability in Subjects With Seasonal Allergic Rhinitis (SAR) Treated With Aerius.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 311 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to test the effectiveness and side effects of desloratadine (Aerius) in patients with hayfever. Patients took desloratadine once a day for 15 days. At the end of therapy, they scored how severe their hayfever symptoms were and how they responded to therapy. Side effects were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desloratadine | Aerius (desloratadine) tablets; 5mg orally once a day in the morning for 15 days |
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2008-12-09
- Last updated
- 2022-02-17
Source: ClinicalTrials.gov record NCT00805584. Inclusion in this directory is not an endorsement.